Eyeworld

JAN 2012

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/78721

Contents of this Issue

Navigation

Page 7 of 71

World view Looking back T David F. Chang, M.D., chief medical editor his month, we invite anterior segment surgeons to direct their attention poste- riorly toward the retina. In the five arti- cles that comprise our cover focus on retina co-morbidities, we call on 14 dif- ferent vitreoretinal specialists to help us with practical dilemmas that cataract surgeons face every week. What is the best way to test visual potential in cataract patients with maculopathy? Does cataract surgery increase the risk of devel- oping or reactivating wet ARMD? How should we time anti-VEGF treatments in patients with macular degeneration or dia- betic macular edema undergoing phaco? How could multifocal IOLs affect treating these conditions in the future? Does lattice degeneration need to be treated prior to cataract surgery? Is routine CME prophylaxis with topi- cal NSAIDs necessary? These are just some of the questions that we pose to our panel of retina experts in this series of complementary articles, and you'll be impressed with how much some of their answers differ from what would have been said just 3-4 years ago. Treatments of the most common retinopathies are evolving at a fast pace, and we anterior seg- ment surgeons value the help and advice of our vitreoretinal colleagues more than ever. January is also a chance to look back at the past year. Femtosecond (FS) laser cataract surgery was certainly the dominant story in 2011 as the first systems were rolled out in the U.S. The curiosity, concerns, and con- troversy surrounding this new technology are unprecedented in so many ways. The technology is amazing, but the formidable financial commit- ment amidst uncertainty as to when and which patients can be billed is definitely unprecedented. In addition, unlike with an IOL that underwent extensive and long-term clinical trials for approval, we are just beginning to collect data on FS laser refractive cataract surgery with precious little peer-reviewed evidence to rely on. Just ponder the differences from when the first accommodating IOL became available in the U.S. We believed then, as now, that accommodating IOLs are the future and will eventually supplant multifocal IOLs. We could review the FDA clinical data, as well as studies from abroad. Within a year, we had a CMS ruling that very clearly defined patient shared billing for the technology. For patients, the value added proposition was easily understandable, desirable, and frequently affordable. Most importantly, any cataract surgeon could offer and gain personal experience with the technology without incurring any major financial risk. Against this background context, the FS laser controversy is certainly appropriate, and EyeWorld will continue to cover the clinical and business developments in the coming year. Did that first accommodating IOL fulfill its promise? The absence of any new accommodating IOLs in the U.S. is another important and disap- pointing story as the Synchrony dual optic IOL (Abbott Medical Optics, Santa Ana, Calif.) was not approved. The fact that so many other highly anticipated technologies remain stalled in the regulatory pipeline is a major concern for anterior segment surgeons and their patients. As high- lighted in our November and December issues, European patients have ac- cess to so many important technologies that Americans don't, and this month I interviewed the guru of disruptive innovation for his thoughts on the innovation cycle in our specialty. The editorial staff at EyeWorld wishes you a happy New Year and looks forward to delivering balanced coverage of the most relevant and impor- tant developments in 2012. David F. Chang, M.D., chief medical editor ASC RS The official publication of the American Society of Cataract & Refractive Surgery January 2012 Publisher Donald R. Long dlong@eyeworld.org Editorial Editor Stephanie Graham stephanie@eyeworld.org Assistant Editor Stacy Majewicz smajewicz@eyeworld.org EyeWorld Staff Writers Faith Hayden faith@eyeworld.org Jena Passut jena@eyeworld.org Production Graphic Designer Julio Guerrero jguerrero@eyeworld.org Production Manager Cathy Stern cstern@eyeworld.org 703-383-5702 Production Assistant Karen Salerni ksalerni@eyeworld.org Contributing Editors Vanessa Caceres Lakeland, Florida Michelle Dalton Reading, Pennsylvania Rich Daly Arlington, Virginia Volume 17 • No. 1 PUBLISHING STAFF Enette Ngoei Singapore Matt Young Malaysia Senior Contributing Editor Maxine Lipner Nyack, New York Advertising Sales ASCRSMedia 4000 Legato Road Suite 700 Fairfax, VA 22033 703-591-2220 fax: 703-591-0614 eyeworld@eyeworld.org www.eyeworld.org Advertising Sales Managers Jeff Brownstein jbrownstein@eyeworld.org 703-788-5745 Paul Zelin pzelin@eyeworld.org 703-383-5729 Classified Sales Cathy Stern cstern@eyeworld.org 703-383-5702 EyeWorld Special Projects and Events Jessica Donohoe jdonohoe@eyeworld.org 703-591-2220 ASCRS Publisher: EYEWORLD (ISSN 1089-0084) is published monthly by ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003; telephone: 703-591-2220; fax: 703-591-0614. Printed in the U.S. Editorial Offices: EYEWORLD News Service, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Advertising Offices: ASCRSMedia, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Copyright 2012, ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. Letters to the editor and other unsolicited material are assumed intended for publication and are subject to editorial review and acceptance. Subscriptions: Requests should be addressed to the publisher. Annual subscription prices: Individual: 1 year, $120; 2 years, $220; 3 years, $320. Institutional: 1 year, $250; 2 years, $330; 3 years, $425. Foreign: 1 year, $240, 2 years $470, 3 years, $700. Back copies: Subject to availability. Contact the publisher. Cost per copy is $15; $30 foreign. All orders for individual or back copies must be accompanied by payment. Requests to reprint, use, or republish: Requests to reprint or use material published herein should be made in writing only to Cathy Stern, EYEWORLD, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. EYEWORLD reprints: To order reprints of material published in EYEWORLD, contact Cathy Stern, EYEWORLD, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4003; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: cstern@eyeworld.org or your salesperson. Change of address: Notice should be sent to the publisher six weeks in advance of effective date. Include old and new addresses and label from recent issue. The publisher cannot accept responsibility for undelivered copies. POSTMASTER: Send change of address to EYEWORLD, 4000 Legato Road, Suite 700, Fairfax, VA 22033. Periodical postage paid at Fairfax, VA 22033 and at additional mailing offices. The ideas and opinions expressed in EYEWORLD do not necessarily reflect those of the editors, publisher, or its advertisers.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - JAN 2012